Taflotan Ophthalmic Solution 0.0015%
Product details
Registration number: SIN13872P
Classification: Prescription Only
Active ingredients: Tafluprost
Strength: 0.015mg/ml
Dosage form: SOLUTION, STERILE
Route: OPHTHALMIC
Registrant: SANTEN PHARMACEUTICAL ASIA PTE. LTD.
ATC code: S01EE05
HSA approval date: 7 October 2010
Manufacturer(s): Santen Pharmaceutical Co., Ltd. Shiga Plant
Manufacturing country/countries: JAPAN
What are the HSA registration number and classification for Taflotan Ophthalmic Solution 0.0015%?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13872P
Classification: Prescription Only
What active ingredients and strength are recorded for Taflotan Ophthalmic Solution 0.0015%?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tafluprost
Strength: 0.015mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Taflotan Ophthalmic Solution 0.0015%?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION, STERILE
Route: OPHTHALMIC
Who is the recorded registrant for Taflotan Ophthalmic Solution 0.0015%?
According to the HSA dataset updated 7 August 2026:
Registrant: SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Which manufacturers and countries are listed for Taflotan Ophthalmic Solution 0.0015%?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Santen Pharmaceutical Co., Ltd. Shiga Plant
Manufacturing country/countries: JAPAN
Where can I look up Taflotan Ophthalmic Solution 0.0015% in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13872P or the exact product name Taflotan Ophthalmic Solution 0.0015%. The general register link does not preselect this product.
What are the source dates for this Taflotan Ophthalmic Solution 0.0015% record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Taflotan Ophthalmic Solution 0.0015% record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13872P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)